envelop
env
protein
synthes
precursor
endoplasm
reticulum
er
follow
complex
glycosyl
cleavag
furin
proteas
transgolgi
complex
matur
trimer
travel
plasma
membran
join
gag
protein
form
infecti
viru
particl
review
start
new
round
infect
bind
receptor
surfac
target
cell
trigger
conform
chang
trimer
expos
bind
site
coreceptor
engag
coreceptor
lead
exposur
fusion
peptid
follow
assembl
bundl
caus
fusion
viral
cellular
membran
membran
fusion
begin
join
membran
outer
lipid
leaflet
process
call
hemifus
continu
fusion
two
membran
lead
format
fusion
pore
fusion
pore
dilat
adequ
size
deliveri
rna
within
core
structur
cytoplasm
viral
protein
surfac
particl
env
protein
repres
chief
target
recognit
host
adapt
immun
system
lead
product
antibodi
recogn
bind
env
protein
despit
variou
strategi
exploit
evad
neutral
antibodi
includ
heavi
glycosyl
mask
epitop
seri
antibodi
abl
neutral
divers
strain
isol
hiv
patient
call
broadli
neutral
antibodi
bnab
review
discoveri
bnab
fuel
hiv
vaccin
research
character
bnab
epitop
env
protein
elucid
b
cell
gener
bnab
addit
neutral
particl
envtarget
antibodi
abl
recruit
natur
killer
nk
cell
engag
fc
receptor
kill
infect
cell
antibodydepend
cellmedi
cytotox
adcc
adccmedi
env
ab
isol
subject
enrol
vaccin
trial
shown
modest
protect
efficaci
surprisingli
mechan
evad
adcc
includ
use
accessori
protein
vpu
nef
downregul
otherwis
interact
env
protein
expos
epitop
adcctrigg
antibodi
review
addit
constitut
activ
intrins
innat
immun
mechan
main
stream
innat
immun
elicit
upon
host
recognit
pathogenassoci
molecular
pattern
pamp
group
host
protein
act
pathogen
recognit
receptor
prr
recognit
event
trigger
signal
cascad
lead
express
cytokin
includ
interferon
ifn
one
function
cytokin
induc
express
protein
directli
restrict
viral
infect
equal
import
function
cytokin
activ
immun
cell
initi
pathogenspecif
adapt
immun
respons
act
togeth
constitut
express
interferoninduc
antivir
protein
form
first
line
host
defens
viral
infect
antivir
protein
oper
varieti
molecular
mechan
target
distinct
step
viru
life
cycl
viral
nucleic
acid
main
pamp
induc
innat
immun
respons
also
becom
target
mani
cellular
antivir
factor
review
exampl
includ
nucleas
oasrnas
l
three
primer
repair
exonucleas
degrad
viral
rna
dna
deaminas
adenosin
deaminas
act
rna
adar
apoliprotein
b
edit
complex
protein
edit
mutat
viral
genom
dntp
hydrolas
sam
domain
hd
domaincontain
protein
diminish
cellular
dna
pool
inhibit
viral
dna
synthesi
factor
myxoviru
resist
tripartit
motifcontain
protein
target
replic
complex
viral
genom
block
viral
multipl
factor
schlafen
protein
kinas
activ
rna
pkr
inhibit
translat
viral
rna
addit
divers
cellular
mechan
attack
viral
nucleic
acid
recent
studi
discov
array
cellular
protein
contribut
control
viral
infect
target
viral
env
inhibit
viral
entri
began
unravel
new
layer
host
antivir
defens
studi
come
appreci
combinatori
strategi
cell
evolv
restrict
viral
entri
target
virtual
everi
stage
env
life
env
synthesi
matur
incorpor
viru
particl
execut
membran
fusion
newli
synthes
env
precursor
fold
er
low
effici
often
misfold
env
protein
subject
erassoci
degrad
erad
process
control
elimin
misfold
protein
one
er
protein
call
ermani
shown
promot
degrad
erassoci
protein
erad
ermani
class
belong
glycosidehydrolas
famili
carbohydrateact
enzym
mediat
trim
residu
among
ermani
first
enzym
gener
ermanl
interact
env
via
lumin
catalyt
domain
mutat
catalyt
site
ablat
activ
degrad
env
protein
function
ermanl
specif
overexpress
famili
erdegrad
enhanc
edem
protein
affect
env
express
thu
specul
ermani
oper
modul
glycosyl
env
interestingli
ermani
requir
function
mitochondri
transloc
protein
call
tspo
diminish
env
express
via
erad
sinc
ermani
deplet
abolish
tspomedi
env
degrad
antivir
activ
ermani
limit
degrad
env
protein
hemagglutinin
ha
glycoprotein
influenza
viru
also
target
ermani
erad
pathway
date
viral
countermeasur
ermani
report
howev
vpr
shown
increas
env
express
absenc
vpr
env
tend
misfold
target
erad
pathway
degrad
ntermin
region
vpr
control
activ
sinc
singl
mutat
disrupt
function
vpr
increas
env
express
remain
determin
whether
vpr
directli
interact
ermani
save
env
degrad
er
eradmedi
degrad
env
exploit
therapeut
purpos
one
exampl
deplet
precursor
er
via
erad
pathway
engin
molecul
call
degradin
contain
antibodi
chain
ctermin
sequenc
erresid
protein
similar
mechan
small
peptid
glycineprolylglycin
amid
abolish
infect
target
viral
env
erad
pathway
degrad
erad
pathway
appear
doubleedg
sword
sinc
vpu
hijack
protein
degrad
mechan
remov
er
prematur
contact
env
thu
avoid
ensur
env
safe
transport
plasma
membran
viru
assembl
precursor
env
trimer
er
move
transgolgi
apparatu
cleav
becom
form
matur
env
trimer
product
three
interferonstimul
gene
isg
guanyl
bind
protein
ifninduc
transmembran
protein
shown
obstruct
cleavag
diminish
incorpor
function
matur
trimer
particl
member
ifninduc
guanosin
triphosphatas
gtpase
member
gbp
famili
report
antagon
varieti
invad
pathogen
includ
virus
bacteria
protozoa
protein
close
relat
inhibit
number
virus
includ
dengu
viru
hepat
c
viru
hcv
encephalomyocard
viru
vesicular
stomat
viru
vsv
identifi
potenti
factor
genomewid
studi
human
gene
share
evolutionari
signatur
known
restrict
factor
supplement
identif
level
primari
cell
macrophag
enhanc
tcr
activ
ectop
express
reduc
infect
particl
diminish
virion
incorpor
deplet
primari
macrophag
elev
infect
enhanc
incorpor
matur
virion
action
appear
specif
retrovirus
sinc
function
vsv
glycoprotein
affect
locat
crucial
inhibitori
effect
intact
ctermin
domain
respons
local
golgi
apparatu
requir
lieu
gtpase
activ
ectop
introduc
caus
two
defect
env
protein
detect
western
blot
cleavag
impair
glycosyl
env
alter
current
unclear
whether
alter
glycosyl
contribut
impair
cleavag
within
gbp
famili
function
appear
specif
affect
env
despit
transgolgi
local
tradeoff
mechan
partial
overcom
inhibit
shut
vpu
express
sinc
vpu
env
synthes
singl
bicistron
mrna
shut
vpu
express
increas
env
express
confer
partial
resist
interestingli
vpu
mutat
caus
loss
vpu
express
identifi
macrophagetrop
brainderiv
strain
indic
might
pressur
resist
high
level
macrophag
protein
also
known
ifninduc
secret
immunostimulatori
glycoprotein
belong
famili
scaveng
receptor
cysteinerich
srcr
domaincontain
protein
respons
stimul
level
increas
variou
cell
line
primari
cell
primari
macrophag
elev
level
report
infect
patient
henc
propos
serolog
marker
diseas
progress
aid
nglycosyl
er
golgi
complex
entri
secretori
pathway
therebi
share
rout
traffick
modif
env
protein
ectop
express
caus
accumul
concomit
reduct
loss
matur
particl
result
impair
infect
nascent
particl
addit
knockdown
sirna
primari
macrophag
increas
virionassoci
infect
also
note
highli
express
macrophag
may
contribut
low
infect
macrophag
inhibit
hiv
virus
also
affect
furindepend
matur
ebola
gp
minim
chang
process
influenza
viru
protein
cellular
suggest
select
action
furin
substrat
lastli
inhibitori
effect
env
might
indirect
given
lack
detect
interact
env
activ
map
two
central
proteinbind
domain
btbpoz
ivr
wherea
ntermin
scaveng
receptor
cystein
rich
srcr
like
domain
dispens
howev
mutagenesi
studi
differ
group
show
one
truncat
mutant
inhibit
env
process
anoth
mutant
inhibit
virion
product
studi
wang
colleagu
also
show
inhibit
virion
product
interact
gag
vimentin
vim
trap
gag
vim
filament
suggest
altern
mechan
unknown
whether
adopt
mechan
counter
factor
antivir
function
conserv
among
primat
except
rhesu
macaqu
interestingli
impair
process
reduc
level
plasma
membran
speci
includ
rhesu
macaqu
howev
function
alway
reduc
infect
nascent
virion
studi
shown
impair
matur
incorpor
virion
might
also
contribut
antivir
action
also
caus
accumul
loss
matur
particl
member
ifitm
famili
includ
among
interferoninduc
shown
inhibit
wide
rang
virus
review
ectop
express
lesser
extent
impair
cleavag
promot
shed
diminish
level
matur
particl
thu
reduc
infect
departur
shown
associ
may
allow
directli
interfer
process
precursor
reach
plasma
membran
warrant
safeti
env
membraneassoci
ringch
recent
report
modifi
env
envelop
protein
virus
downregul
cell
surfac
one
member
march
famili
ringfing
ubiquitin
ligas
transmembran
protein
bear
ring
finger
domain
ntermin
cytoplasm
tail
recruit
enzym
involv
downregul
multipl
transmembran
protein
includ
limit
mhcii
trail
receptor
transferrin
receptor
associ
cellular
transmembran
protein
often
caus
polyubiquitin
target
protein
follow
traffick
lysosom
degrad
anoth
recent
report
substrat
regul
ubiquitin
traffick
turnov
given
prolif
regul
cellular
transmembran
protein
thu
surpris
also
target
viral
envelop
protein
downregul
cell
surfac
ectop
express
antagon
env
also
glycoprotein
siv
mlv
xenotrop
mlvrelat
viru
xmrv
vsv
suggest
broad
antivir
function
mutat
ring
domain
cs
mutat
abrog
antivir
activ
demonstr
depend
ligas
activ
import
note
may
impair
differ
viral
glycoprotein
differ
mechan
exampl
remov
env
cell
surfac
retain
within
lysosom
without
degrad
result
total
level
env
protein
cell
chang
contrast
vsv
g
protein
downregul
cell
surfac
within
cell
due
degrad
lysosom
regardless
mechanist
detail
interact
env
vsv
g
protein
like
alter
level
ubiquitin
examin
antivir
activ
exhibit
member
march
famili
reveal
antivir
function
similar
observ
member
march
famili
inhibit
infect
downregul
env
cellular
surfac
reduc
level
env
incorpor
virion
similar
also
local
plasma
membran
observ
also
get
incorpor
virion
howev
virion
incorpor
remain
controversi
one
group
show
infect
increas
express
detect
releas
viru
particl
wherea
anoth
group
show
similar
also
found
progeni
virion
higher
level
detect
myeloid
cell
monocytederiv
macrophag
mdm
monocytederiv
dendrit
cell
mddc
comparison
primari
cell
unlik
express
highli
induc
type
ifn
mdm
mddc
knockdown
knockout
myeloid
cell
increas
infect
suggest
one
cellular
factor
restrain
infect
macrophag
dendrit
cell
vpr
nef
vpu
antagon
march
protein
result
remain
determin
virus
especi
replic
macrophag
dendrit
cell
evad
inhibit
sinc
march
protein
remov
env
plasma
membran
specul
take
advantag
protein
escap
immunosurveil
addit
target
env
infect
cell
prevent
incorpor
viru
particl
cellular
factor
also
find
way
viru
particl
block
fusion
viral
membran
cellular
membran
beyond
impair
process
produc
cell
incorpor
particl
virion
incorpor
least
partial
due
interact
env
protein
shown
coimmunoprecipit
compar
demonstr
weaker
inhibitori
activ
wherea
show
least
activ
one
mechan
behind
impair
infect
reduct
particl
produc
cell
transfect
dna
provir
dna
altern
mechan
may
also
exist
sinc
particl
produc
cell
also
less
infecti
without
detect
defect
viral
env
protein
addit
ifitm
protein
also
detect
particl
larg
group
envelop
virus
name
murin
leukemia
viru
mlv
monkey
viru
mpmv
vsv
measl
viru
mev
ebola
viru
ebov
west
nile
viru
wnv
dengu
viru
denv
viru
ebv
lead
decreas
viral
infect
ifitm
protein
broad
spectrum
antivir
activ
suggest
gener
mechan
recruit
ifitm
protein
differ
virus
dampen
viral
infect
anoth
factor
virion
member
serin
incorpor
serinc
famili
name
indic
serinc
protein
involv
synthesi
two
serinecontain
lipid
phosphatidylserin
sphingolipid
two
group
report
absenc
nef
protein
lesser
extent
incorpor
particl
impair
infect
contain
transmembran
domain
associ
lipid
raft
particl
often
form
presenc
particl
obstruct
format
viral
fusion
pore
thu
inhibit
entri
target
cell
mechan
action
like
result
increas
rigid
viral
membran
bear
cluster
rather
alter
lipid
composit
viral
membran
interfer
conform
mper
region
env
may
contribut
inhibit
envmedi
cellular
entri
virus
evolv
countermeasur
antagon
nef
protein
downregul
plasma
membran
via
endosomelysosom
pathway
thu
prevent
incorpor
particl
interestingli
env
protein
strain
refractori
inhibit
analog
properti
vsv
g
ebola
gp
viral
envelop
protein
addit
viral
antagonist
glycogag
protein
gammaretrovirus
mlv
protein
equin
infecti
anemia
viru
eiav
also
report
overcom
antivir
function
strategi
differ
virus
indic
broad
antivir
function
entri
mark
fusion
viral
target
cell
membran
process
driven
sequenti
conform
chang
env
trimer
result
bind
receptor
coreceptor
addit
seri
host
inhibitori
mechan
discuss
present
viru
produc
cell
target
disabl
env
viral
membran
target
cell
membran
also
equip
mechan
prevent
fusion
viral
membran
one
promin
exampl
antivir
function
ifitm
protein
discov
genomewid
sirna
screen
host
factor
modul
infect
influenza
viru
subsequ
ifitm
protein
shown
inhibit
entri
shrnabas
screen
aim
identifi
isg
mechanist
studi
reveal
ifitm
protein
hamper
viral
membran
hemifus
andor
block
format
fusion
pore
viru
target
cell
due
increas
rigid
alter
curvatur
ifitmbear
cellular
membran
ifitm
protein
may
modul
membran
fluiditi
interf
intracellular
cholesterol
homeostasi
although
involv
cholesterol
still
controversi
entri
deterr
incom
virus
also
benefit
subcellular
local
ifitm
protein
plasma
membran
endosomeslysosom
cover
rout
viru
entri
ntermin
sequenc
bear
ymel
motif
bind
guid
endosom
lysosom
local
via
endocyt
pathway
contrast
lack
endocyt
motif
rather
carri
krsort
motif
cterminu
guid
traffick
recyclingearli
endosom
ifitm
protein
sole
defens
target
cell
viru
entri
anoth
isg
protect
target
cell
viral
infect
produc
solubl
oxysterol
inhibit
larg
group
virus
includ
murin
herpesviru
vsv
zika
viru
herp
simplex
viru
ebov
nipah
viru
russian
enceph
viru
rift
valley
fever
viru
hepat
c
viru
addit
protect
produc
cell
secret
restrict
viru
entri
surround
uninfect
cell
report
regul
cholesterol
biosynthesi
maintain
cholesterol
homeostasi
function
challeng
observ
mice
demonstr
normal
cholesterol
metabol
clinic
evid
patient
suffer
hereditari
diseas
spastic
paresi
display
high
level
normal
level
cholesterol
disput
role
cholesterol
regul
contrast
accumul
evid
suggest
upregul
macrophag
dendrit
cell
upon
inflammatori
stimul
furthermor
report
accumul
instead
cholesterol
lipid
membran
prevent
envmedi
membran
fusion
modifi
secondari
structur
hivfus
peptid
analog
ifitm
protein
also
oper
virusproduc
cell
alter
glycosyl
lassa
viru
glycoprotein
interestingli
spare
nonenvelop
virus
unlik
ifitm
protein
exampl
shown
hamper
reoviru
uncoat
themat
reson
antivir
action
given
observ
like
prevent
reoviru
entri
delay
proteolyt
process
reoviru
particl
within
late
endosom
independ
produc
also
oper
directli
act
viral
protein
exampl
catalyt
inact
mutant
retain
antivir
function
hcv
porcin
reproduct
respiratori
syndrom
viru
prrsv
direct
interact
hcv
prrsv
order
replic
transmit
virus
need
counter
evad
multilay
host
restrict
defens
system
identif
viral
antagon
host
restrict
factor
also
demonstr
presenc
restrict
context
vivo
viral
infect
driven
select
evolut
specif
viral
counter
measur
inde
viral
antagonist
strategi
discov
host
restrict
mechan
target
entri
began
illumin
divers
viral
evolut
evad
host
restrict
one
viral
countermeasur
use
viral
protein
target
downregul
host
restrict
factor
well
illustr
downregul
nef
mlv
glycogag
eiav
protein
second
strategi
counter
restrict
factor
inhibit
indirect
escap
mechan
one
exampl
mechan
increas
level
env
express
counter
host
inhibit
viru
entri
exemplifi
escap
inhibit
shut
vpu
elev
env
express
anoth
exampl
viral
adapt
escap
shown
vifnul
virus
confer
full
resist
link
novel
envdepend
mechan
env
adapt
vifnul
viru
decreas
viru
fusogen
lead
higher
level
gagpol
packag
virion
increas
level
revers
transcriptas
rt
envmedi
elev
rt
level
prevent
hypermut
third
known
strategi
chang
env
protein
sequenc
thu
adjust
entri
function
gain
resist
host
restrict
viru
entri
observ
viral
escap
mechan
passag
cell
goal
select
virus
resist
mutat
enhanc
celltocel
transmiss
identifi
viral
vpu
env
protein
rescu
replic
cell
similarli
identifi
env
mutat
enhanc
replic
cell
later
found
chang
loop
alon
env
confer
resist
inhibit
abil
env
protein
resist
also
observ
transmit
founder
strain
studi
convincingli
show
env
mutat
aris
evad
autolog
antibodi
month
infect
transform
one
molecular
structur
featur
env
determin
suscept
resist
inhibit
remain
fulli
elucid
relat
envelop
proteinmedi
evas
report
influenza
viru
known
iav
tend
final
membran
fusion
low
ph
late
endosomeslysosom
abundantli
present
escap
restrict
iav
ha
protein
adapt
mediat
membran
fusion
earli
endosom
ph
rel
less
acid
low
level
appear
viral
envelop
protein
resist
ifitm
protein
other
found
env
protein
strain
includ
transmit
founder
isol
abl
resist
inhibit
even
absenc
viral
nef
protein
act
antagonist
map
resist
determin
loop
env
viral
envelop
also
demonstr
capac
overcom
host
restrict
beyond
viru
entri
exampl
passag
sivhiv
chimer
viru
shiv
macaqu
presenc
led
select
shiv
resist
phenotyp
map
viral
env
protein
higher
level
express
resist
viru
separ
studi
report
resist
transmit
founder
type
ii
interferon
resist
activ
also
map
viral
env
support
env
role
counter
replic
sensit
strain
presenc
select
resist
mutat
viral
env
protein
studi
report
gener
role
env
protein
gener
resist
interferon
suppress
one
possibl
chang
env
acquir
higher
replic
capac
compens
loss
infect
result
interferon
inhibit
addit
compensatori
mechan
viral
envelop
protein
abl
directli
counter
specif
host
restrict
factor
one
exampl
antagon
tetherin
env
hervk
env
ebola
glycoprotein
tetherin
known
inhibit
releas
mani
envelop
virus
tether
progeni
virion
cell
surfac
use
vpu
nullifi
tetherin
primat
lentivirus
siv
chimpanze
sooti
mangabey
african
green
monkey
use
nef
antagon
tetherin
contrast
siv
lineag
includ
siv
tetanu
encod
vpu
instead
use
env
tetherin
antagonist
function
domain
analysi
reveal
env
antagonist
activ
tetherin
depend
tyrosin
base
motif
cytoplasm
tail
membran
proxim
region
upon
direct
interact
extracellular
domain
env
ectodomain
tetherin
tyrosin
motif
env
recruit
complex
induc
intracellular
sequestr
tetherin
cell
surfac
accumul
transgolgi
network
recent
studi
isol
differ
patient
reveal
antitetherin
activ
conserv
function
env
ancient
retrovirus
might
also
use
env
protein
overcom
tetherin
inhibit
sinc
youngest
activ
endogen
retroviru
erv
human
genom
hervk
still
preserv
function
env
protein
addit
retrovirus
glycoprotein
gp
ebola
viru
lluvia
viru
also
antagonist
tetherin
ebola
gp
remov
tetherin
cell
surfac
appear
depend
gxxxa
motif
transmembran
domain
adapt
innat
immun
cooper
creat
higher
genet
barrier
viral
envelop
protein
escap
compar
either
immun
respons
alon
exampl
env
engag
constant
battl
antibodymedi
adapt
immun
respons
abil
env
evad
innat
immun
might
limit
need
resist
antibodi
attack
scenario
illustr
loss
resist
transmit
founder
strain
mutat
env
order
resist
autolog
antibodi
infect
progress
one
implic
find
rel
high
level
may
mount
high
enough
inhibitori
pressur
limit
env
mutat
pathway
evad
inhibit
antibodi
thu
creat
synergist
control
infect
equal
possibl
given
interferoninduc
natur
express
subsid
interferon
respons
acut
stage
infect
may
lead
reduct
level
thu
mount
less
pressur
env
allow
env
chang
resist
neutral
antibodi
potenti
interplay
adapt
innat
immun
may
also
explain
need
nef
antagon
even
though
env
full
capac
resist
requir
like
certain
type
neutral
antibodi
target
mper
sequenc
env
abl
sensit
otherwis
resist
env
inhibit
exampl
demonstr
dual
pressur
innat
immun
neutral
antibodi
adapt
immun
driven
evolv
nef
antagon
research
could
illumin
synergist
suppress
viral
envelop
protein
adapt
innat
immun
seemingli
endless
evolut
viral
counter
measur
ensur
viral
surviv
grow
bodi
studi
demonstr
env
protein
primari
antigen
adapt
immun
also
main
target
innat
immun
arsen
antivir
protein
alreadi
discov
either
limit
synthesi
env
protein
deregul
env
glycosyl
impair
env
cleavag
furin
imped
incorpor
matur
env
trimer
particl
addit
antivir
factor
restrict
entri
act
env
directli
alter
physic
properti
viral
membran
cellular
membran
often
enabl
inhibit
broad
rang
virus
cell
use
divers
molecular
mechan
inhibit
entri
mani
virus
far
beyond
illustr
target
viru
entri
gener
import
host
antivir
strategi
figur
tabl
futur
research
expect
provid
insight
molecular
mechan
antivir
protein
restrict
viru
entri
elucid
factor
function
togeth
vivo
creat
optim
antivir
effect
understand
viral
countermeasur
escap
mechan
also
interest
investig
antivir
protein
alter
env
glycoprotein
modul
adapt
immun
respons
bnab
key
effector
adapt
immun
test
clinic
trial
new
hiv
treatment
likewis
restrict
factor
form
key
layer
innat
immun
also
promis
new
approach
treat
even
cure
hiv
infect
applic
gene
therapi
creat
hivresist
hematopoiet
stem
cell
